Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Clee SM, Kastelein JJ, van Dam M, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stulc T, Suda T, Ceska R, Boucher B, Rondeau C, DeSouich C, Brooks-Wilson A, Molhuizen HO, Frohlich J, Genest J Jr, Hayden MR.

J Clin Invest. 2000 Nov;106(10):1263-70.

2.

Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.

Mott S, Yu L, Marcil M, Boucher B, Rondeau C, Genest J Jr.

Atherosclerosis. 2000 Oct;152(2):457-68.

PMID:
10998475
3.

The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.

Hovingh GK, Van Wijland MJ, Brownlie A, Bisoendial RJ, Hayden MR, Kastelein JJ, Groen AK.

J Lipid Res. 2003 Jun;44(6):1251-5. Epub 2003 Apr 16.

4.

Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.

Brousseau ME, Eberhart GP, Dupuis J, Asztalos BF, Goldkamp AL, Schaefer EJ, Freeman MW.

J Lipid Res. 2000 Jul;41(7):1125-35.

5.

Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders.

Pisciotta L, Hamilton-Craig I, Tarugi P, Bellocchio A, Fasano T, Alessandrini P, Bon GB, Siepi D, Mannarino E, Cattin L, Averna M, Cefalù AB, Cantafora A, Calandra S, Bertolini S.

Atherosclerosis. 2004 Feb;172(2):309-20.

PMID:
15019541
6.

Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.

Marcil M, Bissonnette R, Vincent J, Krimbou L, Genest J.

Circulation. 2003 Mar 18;107(10):1366-71.

7.

Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.

Slatter TL, Williams MJ, Frikke-Schmidt R, Tybjaerg-Hansen A, Morison IM, McCormick SP.

Atherosclerosis. 2006 Aug;187(2):393-400. Epub 2005 Oct 12.

PMID:
16225879
8.

ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease.

Kakko S, Kelloniemi J, von Rohr P, Hoeschele I, Tamminen M, Brousseau ME, Kesäniemi YA, Savolainen MJ.

Atherosclerosis. 2003 Feb;166(2):285-90.

PMID:
12535741
9.

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.

Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest J Jr, Kastelein JJ, Hayden MR.

Circulation. 2001 Mar 6;103(9):1198-205.

10.
11.

Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.

Cameron J, Ranheim T, Halvorsen B, Kulseth MA, Leren TP, Berge KE.

Atherosclerosis. 2010 Mar;209(1):163-6. doi: 10.1016/j.atherosclerosis.2009.08.039. Epub 2009 Aug 29.

PMID:
19765707
12.

Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.

Fasano T, Zanoni P, Rabacchi C, Pisciotta L, Favari E, Adorni MP, Deegan PB, Park A, Hlaing T, Feher MD, Jones B, Uzak AS, Kardas F, Dardis A, Sechi A, Bembi B, Minuz P, Bertolini S, Bernini F, Calandra S.

Mol Genet Metab. 2012 Nov;107(3):534-41. doi: 10.1016/j.ymgme.2012.08.005. Epub 2012 Aug 18.

PMID:
22959828
13.

Common and rare ABCA1 variants affecting plasma HDL cholesterol.

Wang J, Burnett JR, Near S, Young K, Zinman B, Hanley AJ, Connelly PW, Harris SB, Hegele RA.

Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1983-9.

14.

HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.

Du XM, Kim MJ, Hou L, Le Goff W, Chapman MJ, Van Eck M, Curtiss LK, Burnett JR, Cartland SP, Quinn CM, Kockx M, Kontush A, Rye KA, Kritharides L, Jessup W.

Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14. Erratum in: Circ Res. 2015 Jul 17;117(3):e40.

15.

An ABCA1 truncation shows no dominant negative effect in a familial hypoalphalipoproteinemia pedigree with three ABCA1 mutations.

Sorrenson B, Suetani RJ, Bickley VM, George PM, Williams MJ, Scott RS, McCormick SP.

Biochem Biophys Res Commun. 2011 Jun 10;409(3):400-5. doi: 10.1016/j.bbrc.2011.05.006. Epub 2011 May 7.

PMID:
21575609
16.
17.

Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.

van Dam MJ, de Groot E, Clee SM, Hovingh GK, Roelants R, Brooks-Wilson A, Zwinderman AH, Smit AJ, Smelt AH, Groen AK, Hayden MR, Kastelein JJ.

Lancet. 2002 Jan 5;359(9300):37-42.

PMID:
11809185
18.

cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.

Haidar B, Denis M, Krimbou L, Marcil M, Genest J Jr.

J Lipid Res. 2002 Dec;43(12):2087-94.

19.

Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.

Choi HY, Karten B, Chan T, Vance JE, Greer WL, Heidenreich RA, Garver WS, Francis GA.

J Biol Chem. 2003 Aug 29;278(35):32569-77. Epub 2003 Jun 16.

20.

ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease.

Hong SH, Rhyne J, Zeller K, Miller M.

Atherosclerosis. 2002 Oct;164(2):245-50. Review.

PMID:
12204794

Supplemental Content

Support Center